Prothena to Present New Data from Alzheimer's Disease Programs at Alzheimer's Association International Conference® 2023 (AAIC®)

DUBLIN--(BUSINESS WIRE)--$PRTA #AAIC2023--Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced participation in the Alzheimer’s Association International Conference® 2023 (A...

Related Keywords

Netherlands ,Amsterdam ,Noord Holland ,Ferenc Mart ,Michael Bachner ,Brian Campbell ,Mark Johnson ,International Conference On Alzheimer ,Corporate Communications ,Company On Twitter Prothenacorp ,Head Of Neurodegeneration Clinical Development ,Exchange Commission ,Prothena Corporation ,Alzheimer Association International Conference ,Nasdaq ,Association International ,Potential Treatment ,Neurodegeneration Clinical Development ,Translational Medicine ,What Progress ,People Living ,Quarterly Report ,Investor Contact ,Senior Director ,Vice President ,Investor Relations ,